Parathyroid Hormone, Cognitive Function and Dementia: A Systematic Review

Background Metabolic factors are increasingly recognized to play an important role in the pathogenesis of Alzheimer’s disease and dementia. Abnormal parathyroid hormone (PTH) levels play a role in neuronal calcium dysregulation, hypoperfusion and disrupted neuronal signaling. Some studies support a significant link between PTH levels and dementia whereas others do not. Methods We conducted a systematic review through January 2014 to evaluate the association between PTH and parathyroid conditions, cognitive function and dementia. Eleven electronic databases and citation indexes were searched including Medline, Embase and the Cochrane Library. Hand searches of selected journals, reference lists of primary studies and reviews were also conducted along with websites of key organizations. Two reviewers independently screened titles and abstracts of identified studies. Data extraction and study quality were performed by one and checked by a second reviewer using predefined criteria. A narrative synthesis was performed due to the heterogeneity of included studies. Results The twenty-seven studies identified were of low and moderate quality, and challenging to synthesize due to inadequate reporting. Findings from six observational studies were mixed but suggest a link between higher serum PTH levels and increased odds of poor cognition or dementia. Two case-control studies of hypoparathyroidism provide limited evidence for a link with poorer cognitive function. Thirteen pre-post surgery studies for primary hyperparathyroidism show mixed evidence for improvements in memory though limited agreement in other cognitive domains. There was some degree of cognitive impairment and improvement postoperatively in observational studies of secondary hyperparathyroidism but no evident pattern of associations with specific cognitive domains. Conclusions Mixed evidence offers weak support for a link between PTH, cognition and dementia due to the paucity of high quality research in this area.

[1]  K. Blennow,et al.  Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease , 2013, PloS one.

[2]  R. Sagar,et al.  Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium. , 2013, European journal of endocrinology.

[3]  A. Tatsioni,et al.  Risk factors for cognitive dysfunction in CKD and hypertensive subjects , 2013, International Urology and Nephrology.

[4]  M. Visser,et al.  Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies. , 2013, American heart journal.

[5]  K. Sworczak,et al.  Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism , 2012, Langenbeck's Archives of Surgery.

[6]  P. Snyder,et al.  The Effects of Serum Calcium and Parathyroid Hormone Changes on Psychological and Cognitive Function in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism , 2011, Annals of surgery.

[7]  Mikko P. Björkman,et al.  Does elevated parathyroid hormone concentration predict cognitive decline in older people? , 2010, Aging clinical and experimental research.

[8]  E. Tacconelli.  Systematic reviews: CRD's guidance for undertaking reviews in health care , 2010 .

[9]  M. Vreugdenhil,et al.  Calcium and normal brain ageing. , 2010, Cell calcium.

[10]  P. Donnan,et al.  Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS) , 2009, Clinical endocrinology.

[11]  Jeffrey E. Lee,et al.  Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. , 2009, Surgery.

[12]  J. Benge,et al.  Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy , 2009, Journal of the International Neuropsychological Society.

[13]  R. Sacco,et al.  Carotid vascular abnormalities in primary hyperparathyroidism. , 2009, The Journal of clinical endocrinology and metabolism.

[14]  R. Lazar,et al.  Neuropsychological features in primary hyperparathyroidism: a prospective study. , 2009, The Journal of clinical endocrinology and metabolism.

[15]  N. Caron,et al.  What Symptom Improvement Can Be Expected After Operation for Primary Hyperparathyroidism? , 2009, World Journal of Surgery.

[16]  T. Murphy,et al.  Relationship between conditions addressed by hemodialysis guidelines and non-ESRD-specific conditions affecting quality of life. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[17]  J. Bilezikian,et al.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. , 2009, The Journal of clinical endocrinology and metabolism.

[18]  M. Anagnostouli,et al.  Dementia as presenting symptom of primary hyperparathyroidism: Favourable outcome after surgery , 2008, Clinical Neurology and Neurosurgery.

[19]  B. Dawson-Hughes,et al.  Vitamin D and neurocognitive dysfunction: preventing "D"ecline? , 2008, Molecular aspects of medicine.

[20]  C. Casella,et al.  [Neurological and psychiatric disorders in primary hyperparathyroidism: the role of parathyroidectomy]. , 2008, Annali italiani di chirurgia.

[21]  C. Liou,et al.  Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism. , 2008, Surgery.

[22]  A. Hofman,et al.  Serum Calcium and Cognitive Function in Old Age , 2007, Journal of the American Geriatrics Society.

[23]  T. Çermik,et al.  Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism , 2007, Neuroradiology.

[24]  C. Ohmann,et al.  Neuropsychiatric and Cognitive Changes after Surgery for Primary Hyperparathyroidism , 2006, World Journal of Surgery.

[25]  J. Svartberg,et al.  Neuropsychological function in relation to serum parathyroid hormone and serum 25–hydroxyvitamin D levels , 2006, Journal of Neurology.

[26]  P. Snyder,et al.  Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. , 2005, Surgery.

[27]  J. Williamson,et al.  Primary Hyperparathyroidism, Cognition, and Health-Related Quality of Life , 2005, Annals of surgery.

[28]  L. Rao,et al.  Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. , 2005, Endocrine reviews.

[29]  D. Andrewes,et al.  A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients , 2005, Clinical endocrinology.

[30]  G. Sonneck,et al.  Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. , 2002, Surgery.

[31]  R. Lal,et al.  Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery. , 2001, Indian journal of medical sciences.

[32]  A. Broadus,et al.  Parathyroid hormone-related protein protects against kainic acid excitotoxicity in rat cerebellar granule cells by regulating L-type channel calcium flux , 1999, Neuroscience Letters.

[33]  K. Kowdley,et al.  Cognitive impairment and intracranial calcification in chronic hypoparathyroidism. , 1999, The American journal of the medical sciences.

[34]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[35]  D. Khudaverdyan,et al.  Effect of the parathyroid hormone—Calcium system on functional activity of the hypothalamus-neurohypophysis complex , 1996, Bulletin of Experimental Biology and Medicine.

[36]  R. Helme,et al.  Bone Density, Vitamin D Nutrition, and Parathyroid Hormone Levels in Women with Dementia , 1995, Journal of the American Geriatrics Society.

[37]  T. Bonner,et al.  Identification and Functional Expression of a Receptor Selectively Recognizing Parathyroid Hormone, the PTH2 Receptor (*) , 1995, The Journal of Biological Chemistry.

[38]  Numann Pj,et al.  Neuropsychologic deficits associated with primary hyperparathyroidism. , 1984 .

[39]  P. De Bastiani,et al.  Cognitive function and regular dialysis treatment. , 1983, Clinical nephrology.

[40]  R. Wyatt,et al.  Serum parathyroid hormone concentrations in senile dementia (Alzheimer's disease). , 1980, Journal of gerontology.

[41]  A. Arieff,et al.  Central nervous system manifestations of hyperparathyroidism. , 1978, The American journal of medicine.

[42]  C. Annweiler,et al.  Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. , 2013, Journal of Alzheimer's disease : JAD.

[43]  D. Watt,et al.  Frontal-Subcortical Dementias , 2012 .

[44]  Jeffrey E. Lee,et al.  Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[45]  G C Roman,et al.  Research criteria for subcortical vascular dementia in clinical trials. , 2000, Journal of neural transmission. Supplementum.

[46]  T. Wetterling,et al.  Secondary hyperparathyroidism and depression in chronic renal failure. , 1995, Nephron.

[47]  T. Ogihara,et al.  Possible participation of calcium-regulating factors in senile dementia in elderly female subjects. , 1990, Gerontology.

[48]  P. Numann,et al.  Neuropsychologic deficits associated with primary hyperparathyroidism. , 1984, Surgery.